Through discovery and innovation, we create solutions
to understand disease risk and find new treatments
to help people live longer and healthier lives.
InterGenetics® is a personalized medicine company focused on molecular diagnostics and targeted therapy for cancer. An innovator in the frontier of genetic medicine, InterGenetics® research discovered CombiSNP®, proprietary gene combinations and DNA assessment technology leading to OncoVue®, the first broad genetic predictive test for breast cancer applicable to all women.
The OncoVue® Test, which has the potential to indicate a woman's risk of developing breast cancer years before the onset of the disease, is performed in our own CLIA-certified, cytogenetics laboratory along with other molecular diagnostic tests through a SNP genotyping platform.
OncoVue® . . . One simple test.
A lifetime of knowledge.